Cargando…

Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations

BACKGROUND: To achieve the elimination of hepatitis B and C, there is an urgent need to develop alternative strategies to increase the access of diagnosis, particularly among key populations such as people living with human immunodeficiency virus (HIV), individuals with coagulopathies and chronic ki...

Descripción completa

Detalles Bibliográficos
Autores principales: Flores, Geane Lopes, Barbosa, Jakeline Ribeiro, Cruz, Helena Medina, Miguel, Juliana Custódio, Potsch, Denise Vigo, Pilotto, José Henrique, Lima, Danielle Malta, Baima Colares, Jeová Keny, Brandão-Mello, Carlos Eduardo, Pires, Marcia Maria Amendola, da Mota, Jurema Corrêa, Bastos, Francisco I, Lewis-Ximenez, Lia Laura, Villar, Livia Melo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080549/
https://www.ncbi.nlm.nih.gov/pubmed/33959230
http://dx.doi.org/10.4254/wjh.v13.i4.504
_version_ 1783685452125962240
author Flores, Geane Lopes
Barbosa, Jakeline Ribeiro
Cruz, Helena Medina
Miguel, Juliana Custódio
Potsch, Denise Vigo
Pilotto, José Henrique
Lima, Danielle Malta
Baima Colares, Jeová Keny
Brandão-Mello, Carlos Eduardo
Pires, Marcia Maria Amendola
da Mota, Jurema Corrêa
Bastos, Francisco I
Lewis-Ximenez, Lia Laura
Villar, Livia Melo
author_facet Flores, Geane Lopes
Barbosa, Jakeline Ribeiro
Cruz, Helena Medina
Miguel, Juliana Custódio
Potsch, Denise Vigo
Pilotto, José Henrique
Lima, Danielle Malta
Baima Colares, Jeová Keny
Brandão-Mello, Carlos Eduardo
Pires, Marcia Maria Amendola
da Mota, Jurema Corrêa
Bastos, Francisco I
Lewis-Ximenez, Lia Laura
Villar, Livia Melo
author_sort Flores, Geane Lopes
collection PubMed
description BACKGROUND: To achieve the elimination of hepatitis B and C, there is an urgent need to develop alternative strategies to increase the access of diagnosis, particularly among key populations such as people living with human immunodeficiency virus (HIV), individuals with coagulopathies and chronic kidney disease (CKD) patients. AIM: To evaluate the use of dried blood spot (DBS) in the detection of hepatitis B virus (HBV) and hepatitis C virus (HCV) markers. METHODS: A total of 430 individuals comprised of people living with HIV, coagulopathies and CKD provided paired serum and DBS samples. HBsAg, anti-HBc and anti-HCV were tested in those samples using a commercial electrochemiluminescence. Demographic and selected behavioral variables were evaluated to assess possible association with HBV and HCV positivity. RESULTS: Using DBS, HBsAg prevalence varied from 3.9% to 22.1%, anti-HBc rates varied from 25.5% to 45.6% and anti-HCV positivity ranged from 15.9% to 41.2% in key populations. Specificities of HBV and HCV tests using DBS varied from 88.9% to 100%. The HBsAg assay demonstrated the best performance in CKD and coagulopathy individuals and the anti-HCV test had a sensitivity and specificity of 100% in people living with HIV. Accuracy of HBV and HCV detection in DBS varied from 90.2% to 100%. In the CKD group, HBsAg positivity was associated with infrequent use of condoms, and anti-HBc positivity was associated with sharing nail cutters/razors/toothbrushes. Anti-HCV reactivity was positively associated with a history of transplantation and length of time using hemodialysis in both specimens. In people living with HIV, only the male gender was associated with anti-HBc positivity in serum and DBS. CONCLUSION: DBS with electrochemiluminescence are useful tools for the diagnosis and prevalence studies of hepatitis B and C among key populations and may increase the opportunity to foster prevention and treatment.
format Online
Article
Text
id pubmed-8080549
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-80805492021-05-05 Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations Flores, Geane Lopes Barbosa, Jakeline Ribeiro Cruz, Helena Medina Miguel, Juliana Custódio Potsch, Denise Vigo Pilotto, José Henrique Lima, Danielle Malta Baima Colares, Jeová Keny Brandão-Mello, Carlos Eduardo Pires, Marcia Maria Amendola da Mota, Jurema Corrêa Bastos, Francisco I Lewis-Ximenez, Lia Laura Villar, Livia Melo World J Hepatol Observational Study BACKGROUND: To achieve the elimination of hepatitis B and C, there is an urgent need to develop alternative strategies to increase the access of diagnosis, particularly among key populations such as people living with human immunodeficiency virus (HIV), individuals with coagulopathies and chronic kidney disease (CKD) patients. AIM: To evaluate the use of dried blood spot (DBS) in the detection of hepatitis B virus (HBV) and hepatitis C virus (HCV) markers. METHODS: A total of 430 individuals comprised of people living with HIV, coagulopathies and CKD provided paired serum and DBS samples. HBsAg, anti-HBc and anti-HCV were tested in those samples using a commercial electrochemiluminescence. Demographic and selected behavioral variables were evaluated to assess possible association with HBV and HCV positivity. RESULTS: Using DBS, HBsAg prevalence varied from 3.9% to 22.1%, anti-HBc rates varied from 25.5% to 45.6% and anti-HCV positivity ranged from 15.9% to 41.2% in key populations. Specificities of HBV and HCV tests using DBS varied from 88.9% to 100%. The HBsAg assay demonstrated the best performance in CKD and coagulopathy individuals and the anti-HCV test had a sensitivity and specificity of 100% in people living with HIV. Accuracy of HBV and HCV detection in DBS varied from 90.2% to 100%. In the CKD group, HBsAg positivity was associated with infrequent use of condoms, and anti-HBc positivity was associated with sharing nail cutters/razors/toothbrushes. Anti-HCV reactivity was positively associated with a history of transplantation and length of time using hemodialysis in both specimens. In people living with HIV, only the male gender was associated with anti-HBc positivity in serum and DBS. CONCLUSION: DBS with electrochemiluminescence are useful tools for the diagnosis and prevalence studies of hepatitis B and C among key populations and may increase the opportunity to foster prevention and treatment. Baishideng Publishing Group Inc 2021-04-27 2021-04-27 /pmc/articles/PMC8080549/ /pubmed/33959230 http://dx.doi.org/10.4254/wjh.v13.i4.504 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Observational Study
Flores, Geane Lopes
Barbosa, Jakeline Ribeiro
Cruz, Helena Medina
Miguel, Juliana Custódio
Potsch, Denise Vigo
Pilotto, José Henrique
Lima, Danielle Malta
Baima Colares, Jeová Keny
Brandão-Mello, Carlos Eduardo
Pires, Marcia Maria Amendola
da Mota, Jurema Corrêa
Bastos, Francisco I
Lewis-Ximenez, Lia Laura
Villar, Livia Melo
Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations
title Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations
title_full Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations
title_fullStr Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations
title_full_unstemmed Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations
title_short Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations
title_sort dried blood spot sampling as an alternative for the improvement of hepatitis b and c diagnosis in key populations
topic Observational Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080549/
https://www.ncbi.nlm.nih.gov/pubmed/33959230
http://dx.doi.org/10.4254/wjh.v13.i4.504
work_keys_str_mv AT floresgeanelopes driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations
AT barbosajakelineribeiro driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations
AT cruzhelenamedina driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations
AT migueljulianacustodio driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations
AT potschdenisevigo driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations
AT pilottojosehenrique driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations
AT limadaniellemalta driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations
AT baimacolaresjeovakeny driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations
AT brandaomellocarloseduardo driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations
AT piresmarciamariaamendola driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations
AT damotajuremacorrea driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations
AT bastosfranciscoi driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations
AT lewisximenezlialaura driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations
AT villarliviamelo driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations